![Rémi Delansorne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rémi Delansorne
Geen lopende functies
Profiel
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd. Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Eerdere bekende functies van Rémi Delansorne
| Bedrijven | Functie | Einde |
|---|---|---|
| ATON | Algemeen Directeur | 12-03-2020 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Corporate Officer/Principal | - |
Opleiding van Rémi Delansorne
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
École Nationale Vétérinaire d'Alfort
 École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
